Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : BCAM International -- Ignore unavailable to you. Want to Upgrade?

To: Dave Gore who wrote (193)	5/24/1998 9:08:00 PM
From: Dave Gore	Read Replies (1) \| Respond to of 333

POTENTIAL INVESTORS: Re-Read this old press release. here is the real reason that this stock is undervalued. The MANAGEMENT, TECHNOLOGY, and POTENTIAL is excellent. This is NOT a $1, $2, or even a $3.00 stock. It is way undervalued. They have since added Stern, the PR firm, to help build value. Be patient, Stern was just hired. Good PR firms work miracles. My TGSK went from $1.10 to $3.00 shortly after the PR FIRM took over. Once the word get out and the volume picks up, we are on our way. Major strategies are bieng planned as we speak. Nov. 5 /PRNewswire/ -- BCAM International Inc. BCAM announced today the appointment of Kenneth C. Riscica as its Vice President - Finance, Chief Financial Officer, Treasurer and Secretary. Mr. Riscica formerly was a partner in charge of an emerging companies practice group with Arthur Andersen & Co. LLP, having been a partner from 1987 to 1992 (after joining the firm in 1976). More recently, Ken has served as Managing Director of Riscica Associates, Inc., a financial and management consultant firm and as Chief Financial Officer of Magna-Lab, Inc., a publicly traded medical technology company. "Ken joins the senior management team of BCAM at a critical turning point for the Company," said Michael Strauss, Chairman and Chief Executive Officer of BCAM. "My strategy to realize value for our shareholders involves three elements: (i) partnering with industry leaders for our Intelligent Surface Technology ("IST"), (ii) acquisition of stable complementary businesses and (iii) enhancing the potential for the proprietary "human factor engineering" software of our HumanCAD(R) Systems Division. In 1997 three critical elements of the plan came to fruition: (i) the first commercial application of IST was rolled out by Cadillac (the first intelligent auto seat), (ii) the acquisition of Drew Shoe, a $15 million manufacturer of medical footwear and (iii) the HumanCAD(R) Systems Division, which markets ergonomic(human factor) software for the PC, has relaunched ManneQuin PRO as its flagship product targeted at the Computer Aided Design (CAD) market and ManneQuinONSITE which provides architects, space designers and facility managers with scaleable, accurate human factors data. "The future for BCAM now involves new acquisitions, related financing, cost management, integration of the businesses and financing the rollout of exciting new software products," said Mr. Strauss. "Ken brings extensive business experience in financing, mergers and acquisitions, change management, cost containment as well as financial planning and control. He will play a key role in helping me build value for BCAM's shareholders. I am delighted to have Ken on our team." "Mike Strauss has reinvented BCAM," said Kenneth Riscica. "He has a very aggressive agenda to build the Company involving acquisitions in the medical footwear arena and the launch of a basket of high potential software products as well as incorporating BCAM's IST into several products. Making the acquisitions, financing the growth and managing for profitability are present opportunities for the Company. I am excited about the opportunity to help build value for the BCAM shareholders."